Search research articles
Contact Us
Filters
Showing results (181-190 of 233) with videos related to
Page
of 24
Sort By:
Bioorganic & Medicinal Chemistry
|
July 22, 2004
Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors
Aloke K Dutta, Sylesh K Venkataraman, Xiang-Shu Fei, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters
Shijun Zhang, Fernando Fernandez, Stuart Hazeldine, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology
|
November 1, 1992
How often is dysplasia diagnosed by biopsy or smear examination? Application of a maximum likelihood based method to the assessment of detection rates in the nasal mucosa of nickel workers
A M Downs, M Boysen, R Voss, et al.
Biochemical Pharmacology
|
December 31, 2003
Structure-activity relationships for substrate recognition by the human dopamine transporter
Michael Appell, Janet L Berfield, Lijuan C Wang, et al.
The Journal of Biological Chemistry
|
September 24, 2017
Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding
Sathya Challasivakanaka, Juan Zhen, Margaret E Smith, et al.
Journal of Medicinal Chemistry
|
April 16, 2008
Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity
Swati Biswas, Stuart Hazeldine, Balaram Ghosh, et al.
Chemmedchem
|
October 13, 2012
Structural exploration of (3S,6S)-6-benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine analogues: identification of potent triple monoamine reuptake inhibitors as potential antidepressants
Soumava Santra, Sanjib Gogoi, Bhaskar Gopishetty, et al.
ACS Chemical Neuroscience
|
January 21, 2017
A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson's Disease
Banibrata Das, Ashoka Kandegedara, Liping Xu, et al.
ACS Chemical Neuroscience
|
April 12, 2021
Novel Potent Dopamine-Norepinephrine and Triple Reuptake Uptake Inhibitors Based on Asymmetric Pyran Template and Their Molecular Interactions with Monoamine Transporters
Soumava Santra, Sandhya Kortagere, Seenuvasan Vedachalam, et al.
ACS Chemical Neuroscience
|
June 25, 2014
Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates
Gyan Modi, Chandrashekhar Voshavar, Sanjib Gogoi, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 233) with videos related to
Sort By:
Page
of 24
Bioorganic & Medicinal Chemistry
|
July 22, 2004
Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors
Aloke K Dutta, Sylesh K Venkataraman, Xiang-Shu Fei, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters
Shijun Zhang, Fernando Fernandez, Stuart Hazeldine, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology
|
November 1, 1992
How often is dysplasia diagnosed by biopsy or smear examination? Application of a maximum likelihood based method to the assessment of detection rates in the nasal mucosa of nickel workers
A M Downs, M Boysen, R Voss, et al.
Biochemical Pharmacology
|
December 31, 2003
Structure-activity relationships for substrate recognition by the human dopamine transporter
Michael Appell, Janet L Berfield, Lijuan C Wang, et al.
The Journal of Biological Chemistry
|
September 24, 2017
Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding
Sathya Challasivakanaka, Juan Zhen, Margaret E Smith, et al.
Journal of Medicinal Chemistry
|
April 16, 2008
Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity
Swati Biswas, Stuart Hazeldine, Balaram Ghosh, et al.
Chemmedchem
|
October 13, 2012
Structural exploration of (3S,6S)-6-benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine analogues: identification of potent triple monoamine reuptake inhibitors as potential antidepressants
Soumava Santra, Sanjib Gogoi, Bhaskar Gopishetty, et al.
ACS Chemical Neuroscience
|
January 21, 2017
A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson's Disease
Banibrata Das, Ashoka Kandegedara, Liping Xu, et al.
ACS Chemical Neuroscience
|
April 12, 2021
Novel Potent Dopamine-Norepinephrine and Triple Reuptake Uptake Inhibitors Based on Asymmetric Pyran Template and Their Molecular Interactions with Monoamine Transporters
Soumava Santra, Sandhya Kortagere, Seenuvasan Vedachalam, et al.
ACS Chemical Neuroscience
|
June 25, 2014
Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates
Gyan Modi, Chandrashekhar Voshavar, Sanjib Gogoi, et al.
Page
of 24